STATEN ISLAND, N.Y., Jan. 23, 2024 /PRNewswire/ Â Acurx Pharmaceuticals, Inc. , a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat.
/PRNewswire/ Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ: "ACXP"), a late-stage biopharmaceutical company developing a new class of small.